Hologicvs.IDEXX Laboratories
HOLX vs IDXX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
IDEXX Laboratories is about 2.6× larger than Hologic by market cap; Hologic trades at the lower P/E (31.2 vs 39.0); year to date, Hologic leads (+2.0% vs −17.3%).
Side by side
| HOLX | IDXX | |
|---|---|---|
| Market cap | $17B | $44.4B |
| Price | — | $550.01 |
| Today | — | −1.7% |
| Return YTD | +2.0% | −17.3% |
| Return 1Y | −3.5% | −13.3% |
| P/E | 31.2 | 39.0 |
| P/S | 4.1 | 9.8 |
| P/B | 3.2 | 27.6 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
HologicHOLX
Women's health defines the range here, from molecular diagnostic tests to mammography systems and surgical products.
Full HOLX profile →IDEXX LaboratoriesIDXX
Vets are the customers. IDEXX sells the analysers that sit in the clinic, runs the reference laboratories that handle samples sent out, and writes the software the practice runs on.
Full IDXX profile →More HOLX & IDXX comparisons
Other head-to-heads in the Diagnostics segment.
See where HOLX and IDXX sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →